Yinxiang Lv
发表
Jimin Gao,
Xiaoxiao Yu,
Ai Zhao,
2020,
Endocrine, metabolic & immune disorders drug targets.
Ying Cai,
Rongrong Liu,
Xiaoxiao Zheng,
2017,
Anti-cancer drugs.
Qiuyan Duan,
Yinxiang Lv,
Bijian Lan,
2022,
ACS applied materials & interfaces.
Gut dysbiosis is associated with the reduced exercise capacity of elderly patients with hypertension
X. Lv,
Genxiang Mao,
Li-yue Zhu,
2018,
Hypertension Research.
Qiyu Zhang,
Yihu Zheng,
F. Yu,
2011,
Journal of Cancer Research and Clinical Oncology.
Jun Peng,
Yinxiang Lv,
Chaochao Wu,
2020,
The Journal of international medical research.
Peng Zhang,
Yinxiang Lv,
Zheng Chen,
2020,
American journal of translational research.
P. Zhao,
W. Fang,
Yun Luo,
2017,
Oncotarget.
Y. Huo,
Rongrong Liu,
Yinxiang Lv,
2016,
Drug design, development and therapy.
Y. Huo,
Rongrong Liu,
Yinxiang Lv,
2016,
Drug design, development and therapy.
J. Qian,
Zhangfa Song,
Yinxiang Lv,
2017,
Cellular Physiology and Biochemistry.